Group 1 - Gold stocks experienced significant declines in the afternoon, with notable drops including Chifeng Jilong Gold Mining down 5.54% to HKD 29.32, Shandong Gold down 3.69% to HKD 36.5, China Gold International down 2.94% to HKD 158.4, and Zijin Mining down 2.14% to HKD 146.3 [1][1] - Precious metals saw a broad sell-off on Wednesday, with spot silver dropping over 3%, spot gold down more than 1%, spot palladium falling over 5%, and spot platinum declining by more than 8% [1][1] - UBS's latest report indicates that the recent rise in gold prices lacks strong fundamentals, suggesting that the December rally is not driven by independent positive factors for gold but rather benefiting from the surges in silver, platinum, and palladium [1][1] Group 2 - Starting Thursday, Bloomberg Commodity Index will adjust the weights of various commodities, which may lead passive tracking funds to sell some contracts to align with the new weight configurations [2] - Longjiang Securities noted that due to the previous significant rise in precious metals, there is an expectation of some contract sell-offs, although the overall trend of increasing allocation remains unchanged [2]

Core Viewpoint - The gold stocks experienced significant declines in the afternoon trading session, with major companies like Chifeng Jilong Gold Mining, Shandong Gold Mining, China National Gold Group, and Zijin Mining all reporting losses. This downturn is attributed to a broader drop in precious metals, including silver, gold, palladium, and platinum, indicating a potential shift in market dynamics for these commodities [1] Group 1: Company Performance - Chifeng Jilong Gold Mining (600988) saw a decline of 5.54%, trading at 29.32 HKD [1] - Shandong Gold Mining (600547) dropped by 3.69%, with shares priced at 36.5 HKD [1] - China National Gold Group (600916) fell by 2.94%, trading at 158.4 HKD [1] - Zijin Mining (02259) decreased by 2.14%, with a current price of 146.3 HKD [1] Group 2: Market Trends - Precious metals experienced a significant sell-off, with spot silver down over 3%, gold down more than 1%, palladium down over 5%, and platinum down more than 8% [1] - UBS's latest report suggests that the recent rise in gold prices lacks strong fundamentals, indicating that the current rally is not driven by independent positive factors for gold but rather by the performance of silver, platinum, and palladium [1] - The relationship between gold and real interest rates has reportedly broken down, with significant acceleration in residuals, which typically signals a potential correction [1] Group 3: Index Adjustments - Starting Thursday, Bloomberg Commodity Index will adjust the weights of various commodities, which may lead to passive tracking funds selling some contracts to align with the new weight configurations [1] - Despite the adjustments, the trend towards increasing allocation in precious metals is expected to continue [1]

Core Viewpoint - Gold stocks experienced significant declines, with major companies like Chifeng Jilong Gold Mining Co. Ltd. and Shandong Gold Mining Co. Ltd. seeing drops of 5.54% and 3.69% respectively, indicating a broader downturn in the precious metals market [1] Group 1: Market Performance - Precious metals saw a sharp decline on Wednesday, with spot silver dropping over 3%, spot gold falling more than 1%, spot palladium decreasing over 5%, and spot platinum declining by more than 8% [1] - Chifeng Gold was reported at 29.32 HKD, Shandong Gold at 36.5 HKD, China National Gold International at 158.4 HKD, and Zijin Mining International at 146.3 HKD, reflecting the downward trend in gold stocks [1] Group 2: Analyst Insights - UBS's latest report suggests that the recent rise in gold prices lacks substantial support, indicating that the December rally was not driven by independent positive factors for gold but rather benefited from the surges in silver, platinum, and palladium [1] - The relationship between gold and real interest rates has reportedly broken down, with significant acceleration in residuals, which typically signals a potential correction in the market [1] Group 3: Commodity Index Adjustments - Starting Thursday, Bloomberg Commodity Index will adjust the weights of various commodities, which may lead passive tracking funds to sell some contracts to align with the new weight configurations [1] - Despite the adjustments, the trend of increasing allocation towards precious metals is expected to continue [1]

Group 1 - The core viewpoint of the articles indicates that the gold industry is experiencing upward price movements, with domestic gold jewelry prices rising, suggesting a positive outlook for gold investments [1][2] - The China Securities Index for gold industry stocks (931238) shows mixed performance among its constituent stocks, with notable gains from companies like Zhuhai Group and Yimin Group, while Chifeng Gold leads the declines [1] - Tianfeng Securities believes that the logic behind gold's upward trend is deepening, particularly in light of events in Venezuela, positioning gold as a strong asset against disorder [1] Group 2 - As of December 31, 2025, the top ten weighted stocks in the China Securities Index for gold industry stocks account for 63.58% of the index, highlighting the concentration of investment in a few key players [2] - The gold stock ETF fund closely tracks the performance of the China Securities Index for gold industry stocks, which includes 50 large-cap companies involved in gold mining, refining, and sales [1]

Major Events - Yunzhisheng (09678) secured a regional medical cooperation contract worth over 20 million [1] - Kelun-Biotech (06990) received breakthrough therapy designation from NMPA for TROP2 ADC drug in combination with pembrolizumab for treating PD-L1 positive locally advanced or metastatic non-small cell lung cancer [1] - InSilico Medicine (03696) entered into an 8.88 billion USD multi-year collaboration for anti-tumor drug development with Sihuiya [1] - Hutchison China MediTech (00013) is conducting a Phase III study on surufatinib combined with camrelizumab for first-line treatment of pancreatic ductal adenocarcinoma [1] - Ascletis Pharma-B (01672) announced FDA approval for IND of ASC30 in a 13-week Phase II study in diabetic patients [1] - Foryou Medical (01696) received quality standard inspection approval for its reauthorized injectable botulinum toxin from the Chinese National Medical Products Administration [1] - CanSino Biologics (06185) obtained clinical trial approval in China for its 24-valent pneumococcal polysaccharide conjugate vaccine [1] - Stone Group (02005) received drug production registration approval for perindopril and amlodipine tablets [1] - Sunny Optical Technology (02382) proposed to spin off its automotive optical business for independent listing on the Hong Kong Stock Exchange [1] - Dongyang Sunshine Pharmaceutical (06887) completed the first patient enrollment for HECN30227 in China [1] - Haitong International's subsidiary plans to sell 100% equity of Guohua Machinery for 342 million [1] - Yuexiu Property (00123) subsidiary intends to sell 73.74% actual equity in Hangzhou Yueyun [1] - CIMC Group (02039) subsidiary CIMC Shilianda plans to introduce strategic investors through capital increase and transfer of a small number of old shares [1] Operating Performance - Chifeng Jilong Gold Mining (06693) expects annual net profit attributable to shareholders to be approximately 3 billion to 3.2 billion, an increase of about 70% to 81% year-on-year [2] - Corning Hospital (02120) anticipates outpatient visits to reach approximately 720,200 in 2025, a year-on-year increase of 29% [2] - Seres (09927) reported total vehicle sales of 63,700 units in December, a year-on-year increase of 53.54% [2] - Xiehe New Energy (00182) reported an equity power generation of 790.32 GWh in December [2] - Country Garden (02007) reported contract sales amounting to approximately 2.69 billion attributable to shareholders in December [2]

Core Viewpoint - The company, Chifeng Jilong Gold Mining Co., Ltd. (06693.HK), expects a significant increase in net profit for the fiscal year 2025, projecting a net profit attributable to shareholders of approximately RMB 3 billion to RMB 3.2 billion, representing a year-on-year increase of about 70% to 81% [1] Financial Projections - The company anticipates a net profit attributable to shareholders, excluding non-recurring gains and losses, of approximately RMB 2.97 billion to RMB 3.17 billion for 2025, which indicates a year-on-year increase of about 75% to 86% [1] - The expected increase in net profit amounts to approximately RMB 1.24 billion to RMB 1.44 billion compared to the previous year [1]

Core Viewpoint - Chifeng Jilong Gold Mining Co., Ltd. (06693) expects a significant increase in net profit for the fiscal year 2025, driven by higher gold production and sales prices [1] Financial Performance - The company anticipates a net profit attributable to shareholders of approximately RMB 3 billion to RMB 3.2 billion for 2025, representing an increase of about RMB 1.236 billion to RMB 1.436 billion compared to the previous year, which is a year-on-year growth of approximately 70% to 81% [1] - The expected net profit after deducting non-recurring gains and losses is projected to be around RMB 2.97 billion to RMB 3.17 billion, with an increase of about RMB 1.27 billion to RMB 1.47 billion year-on-year, translating to a growth of approximately 75% to 86% [1] Production and Pricing Factors - The company's anticipated gold production for 2025 is approximately 14.4 tons, with the average sales price of gold products expected to rise by about 49% year-on-year [1] - Enhanced profitability of domestic and overseas mining enterprises is also a contributing factor to the expected financial performance [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不對因本公告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 重要內容提示： 本公司預計2025年年度實現歸屬於上市公司股東的淨利潤約為人民幣300,000 萬元到人民幣320,000萬元，與上年同期（法定披露數據）相比，將增加約人民 幣123,566萬元到人民幣143,566萬元，同比增加約70%到81%；預計2025年年度 實現歸屬於上市公司股東的扣除非經常性損益後的淨利潤約為人民幣297,000 萬元到人民幣317,000萬元，與上年同期（法定披露數據）相比，將增加約人民 幣126,975萬元到人民幣146,975萬元，同比增加約75%到86%。 1 一、本期業績預告情況 Chifeng Jilong Gold Mining Co., Ltd. 赤峰吉隆黃金礦業股份有限公司 （H股股份代號：6693） （於中華人民共和國註冊成立的股份有限公司） （一）業績預告期間 正面盈利預告 赤峰吉隆黃金礦業股份有限公司（「本公司」或「公司」，連同其附屬公司為「本 集團」 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 赤峰吉隆黃金礦業股份有限公司 第 1 頁 共 11 頁 v 1.1.1 FF301 呈交日期: 2026年1月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 600988 | 說明 | | 於上海證券交易所上市之A股 | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,663,911,378 | RMB | | 1 RMB | | 1,663,911,378 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 1,663,911,378 | RMB | | 1 RMB | | ...

Group 1 - The core viewpoint of the article highlights a decline in gold prices, which negatively impacted the performance of gold stocks in China [1] - China Silver Group (00815) experienced a drop of 5.63%, while Lingbao Gold (03330) fell by 3.25% [1] - Other notable declines include Shandong Gold (01787) down 2.67%, Zhaojin Mining (01818) down 2.67%, and Zijin Mining International (02259) down 2.35% [1] Group 2 - The decline in international gold prices was attributed to profit-taking by some investors, with New York February futures closing at $4343.6 per ounce, a decrease of approximately 4.6% [1] - Spot gold prices briefly approached the $4300 per ounce mark [1]